Grunenthal Italy News and Activities

Grunenthal Italy is owned by Grunenthal. Grunenthal has a direct presence in 5 countries.

Grunenthal has 5 subsidiaries including Averitas Pharma, Grunenthal France and Grunenthal Italy.

They are in:

• Pharmaceuticals67%
• Biotechnology33%

View the org chart displaying its 4 main executives

Most searched biographies at Grunenthal Italy

• Ana Martins, General Manager
• Filippo Quattrone, Plant Manager, Local Production
• Isabella Masserini, Head of Regulatory Affairs & Drug Safety

Create your alert
to follow the executive moves at Grunenthal Italy.

Grunenthal has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Grunenthal Italy

Social media about Grunenthal Italy

• Grunenthal Italy on Wikipedia, Google News & Yahoo Finance
• Grunenthal Italy on LinkedIn, X (Twitter) & YouTube